Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Utrogestan for Preterm Birth Prevention in Twin Pregnancy
NCT02329535Terminated
- Sponsor
- Emek Medical Center
- Start
- Jan 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone in preterm birth (2 arms), sponsored by Emek Medical Center. Primary endpoint: Preterm delivery. Started Jan 2015; status: terminated.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT02329535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02329535.